Some of the ways that policy makers, medical providers and patients can reduce the financial toxicity of cancer treatment.
Understanding the “financial toxicity” of cancer, including what it involves, how it impacts us and who is most affected.
Many cancer patients are receiving unexpected bills from out-of-network providers after surgery.
In ‘An American Sickness’, Elisabeth Rosenthal explains why our healthcare costs are out of control and offers practical steps we can take as individuals as well as a blueprint for reforms.
Cancer research stories worth following this winter included reports on new approaches to immunotherapy currently being tested in clinical trials.
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
How is the practice of “step therapy” affecting patients?
Let’s keep moving forward in 2017 and address health care access issues, including out-of-pocket costs, that are priorities for most Americans.
Prominent issues in cancer research this year included finding ways to make immune system therapies safer and effective for more patients, and the need to make new cancer medicines more affordable.
Possible health policy changes in the coming months could be critical for anyone affected by or potentially affected by cancer.